Thrivent Financial for Lutherans’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Buy |
4,097
+3
| +0.1% | +$864 | ﹤0.01% | 1811 |
|
|
2025
Q4 | $1.24M | Sell |
4,094
-100
| -2% | -$31.2K | ﹤0.01% | 1789 |
|
|
2025
Q3 | $1.18M | Sell |
4,194
-185
| -4% | -$50.3K | ﹤0.01% | 1688 |
|
|
2025
Q2 | $1.06M | Sell |
4,379
-139
| -3% | -$32.9K | ﹤0.01% | 1748 |
|
|
2025
Q1 | $1.1M | Sell |
4,518
-12
| -0.3% | -$3.61K | ﹤0.01% | 1646 |
|
|
2024
Q4 | $1.49M | Buy |
4,530
+32
| +0.7% | +$10.9K | ﹤0.01% | 1647 |
|
|
2024
Q3 | $1.5M | Buy |
4,498
+3,675
| +447% | +$1.17M | ﹤0.01% | 1649 |
|
|
2024
Q2 | $225K | Sell |
823
-2,735
| -77% | -$795K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $1.23M | Sell |
3,558
-16
| -0.4% | -$5.26K | ﹤0.01% | 1769 |
|
|
2023
Q4 | $1.15M | Sell |
3,574
-246
| -6% | -$77.1K | ﹤0.01% | 1748 |
|
|
2023
Q3 | $1.37M | Sell |
3,820
-7,747
| -67% | -$2.99M | ﹤0.01% | 1553 |
|
|
2023
Q2 | $4.39M | Buy |
11,567
+7,777
| +205% | +$3.16M | 0.01% | 910 |
|
|
2023
Q1 | $1.81M | Buy |
3,790
+2
| +0.1% | +$936 | ﹤0.01% | 1361 |
|
|
2022
Q4 | $1.59M | Sell |
3,788
-3,741
| -50% | -$1.51M | ﹤0.01% | 1410 |
|
|
2022
Q3 | $3.14M | Sell |
7,529
-4
| -0.1% | -$1.99K | 0.01% | 968 |
|
|
2022
Q2 | $3.73M | Sell |
7,533
-1,697
| -18% | -$884K | 0.01% | 921 |
|
|
2022
Q1 | $5.2M | Buy |
9,230
+3,835
| +71% | +$2.31M | 0.01% | 879 |
|
|
2021
Q4 | $4.08M | Sell |
5,395
-430
| -7% | -$322K | 0.01% | 985 |
|
|
2021
Q3 | $4.34M | Sell |
5,825
-18
| -0.3% | -$13.5K | 0.01% | 951 |
|
|
2021
Q2 | $3.77M | Buy |
5,843
+2
| +0% | +$1.22K | 0.01% | 1050 |
|
|
2021
Q1 | $3.34M | Sell |
5,841
-643
| -10% | -$381K | 0.01% | 1105 |
|
|
2020
Q4 | $3.78M | Sell |
6,484
-13,152
| -67% | -$7.49M | 0.01% | 977 |
|
|
2020
Q3 | $10.1M | Buy |
19,636
+2,728
| +16% | +$1.38M | 0.03% | 594 |
|
|
2020
Q2 | $7.63M | Sell |
16,908
-23,391
| -58% | -$10.3M | 0.02% | 613 |
|
|
2020
Q1 | $14.1M | Sell |
40,299
-28,612
| -42% | -$10.5M | 0.05% | 398 |
|
|
2019
Q4 | $25.5M | Buy |
68,911
+46,927
| +213% | +$16.5M | 0.07% | 316 |
|
|
2019
Q3 | $7.32M | Buy |
21,984
+9,496
| +76% | +$3.1M | 0.02% | 582 |
|
|
2019
Q2 | $3.9M | Buy |
12,488
+86
| +0.7% | +$25.8K | 0.01% | 741 |
|
|
2019
Q1 | $3.79M | Buy |
12,402
+7,313
| +144% | +$1.97M | 0.01% | 748 |
|
|
2018
Q4 | $1.18M | Buy |
5,089
+221
| +5% | +$59.3K | ﹤0.01% | 1063 |
|
|
2018
Q3 | $1.52M | Buy |
4,868
+253
| +5% | +$78.5K | ﹤0.01% | 1025 |
|
|
2018
Q2 | $1.33M | Buy |
4,615
+35
| +0.8% | +$9.66K | ﹤0.01% | 1082 |
|
|
2018
Q1 | $1.15M | Buy |
4,580
+162
| +4% | +$41.2K | ﹤0.01% | 1159 |
|
|
2017
Q4 | $1.05M | Buy |
4,418
+148
| +3% | +$35.9K | ﹤0.01% | 1221 |
|
|
2017
Q3 | $949K | Buy |
4,270
+70
| +2% | +$15.8K | ﹤0.01% | 1198 |
|
|
2017
Q2 | $950K | Buy |
4,200
+290
| +7% | +$63.2K | ﹤0.01% | 1152 |
|
|
2017
Q1 | $779K | Buy |
3,910
+350
| +10% | +$67.4K | ﹤0.01% | 1309 |
|
|
2016
Q4 | $649K | Buy |
3,560
+310
| +10% | +$52.8K | ﹤0.01% | 1378 |
|
|
2016
Q3 | $532K | Sell |
3,250
-10,410
| -76% | -$1.58M | ﹤0.01% | 1426 |
|
|
2016
Q2 | $1.95M | Buy |
13,660
+310
| +2% | +$44.2K | 0.01% | 873 |
|
|
2016
Q1 | $1.82M | Buy |
13,350
+280
| +2% | +$36.8K | 0.01% | 893 |
|
|
2015
Q4 | $1.81M | Buy |
13,070
+10,770
| +468% | +$1.49M | 0.01% | 880 |
|
|
2015
Q3 | $309K | Buy |
2,300
+200
| +10% | +$28.8K | ﹤0.01% | 1429 |
|
|
2015
Q2 | $316K | Buy |
2,100
+500
| +31% | +$71.5K | ﹤0.01% | 1369 |
|
|
2015
Q1 | $216K | Buy |
+1,600
| New | +$198K | ﹤0.01% | 1562 |
|
Other funds holding BIO
VCM
VPM
AI
